Funded Tech Companies
Immune Design
Wondering who provided funding to Immune Design? Sanofi-Genzyme BioVentures, Topspin Partners and The Column Group invested in this biopharmaceutical company.
Company Overview
Company Name
Immune Design
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1616 Eastlake Ave. East 310
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Website
Email Address
Company Background Information
Overview
Immune Design is a breakthrough therapeutic vaccine product development company utilizing two proprietary and integrated platform technologies.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/24/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carlos Paya
Chief Medical Officer
Sergey Yurasov
Chief Scientific Officer
Jan Meulen
Vice President
Frank Hsu
Vice President
Sandy Mohan
Vice President
Melanie Morrison
VP - Bus. Development
Wayne Gombotz
VP - Finance
Stephen Brady
VP - Regulatory Affairs
Heidi Petersen
Company Investors
- Sanofi-Genzyme BioVentures (Bernard Davitian)
- Topspin Partners
- The Column Group (Peter Svennilson)
- ProQuest Investments (Alain Schreiber)
- Osage Partners
- Versant Ventures (Brian Atwood)
- Alta Partners (Ed Penhoet)
- The Column Group (Richard Klausner)
Browse more funded tech companies:
Immune Control | Immune Pharmaceuticals
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs